These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11730409)

  • 21. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
    Defronzo RA; Mehta RJ; Schnure JJ
    Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angioneurotic edema as a side effect of pioglitazone.
    Shadid S; Jensen MD
    Diabetes Care; 2002 Feb; 25(2):405. PubMed ID: 11815525
    [No Abstract]   [Full Text] [Related]  

  • 24. Rosiglitazone and hepatic failure.
    Freid J; Everitt D; Boscia J
    Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
    de Souza CJ; Eckhardt M; Gagen K; Dong M; Chen W; Laurent D; Burkey BF
    Diabetes; 2001 Aug; 50(8):1863-71. PubMed ID: 11473050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.
    Digby JE; Montague CT; Sewter CP; Sanders L; Wilkison WO; O'Rahilly S; Prins JB
    Diabetes; 1998 Jan; 47(1):138-41. PubMed ID: 9421389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe but reversible cholestatic liver injury after pioglitazone therapy.
    Pinto AG; Cummings OW; Chalasani N
    Ann Intern Med; 2002 Nov; 137(10):857. PubMed ID: 12435231
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocellular injury in a patient receiving pioglitazone.
    Maeda K
    Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
    Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
    Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
    Hachey DM; O'Neil MP; Force RW
    Ann Intern Med; 2000 Nov; 133(9):752. PubMed ID: 11074926
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
    Kallen CB; Lazar MA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
    Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
    Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
    Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
    Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosiglitazone.
    Diabetes Obes Metab; 2000 Apr; 2(2):117. PubMed ID: 11220523
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver failure in a patient treated with long-term rosiglitazone therapy.
    Gouda HE; Khan A; Schwartz J; Cohen RI
    Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetes therapy related to etiology. Indications, uses and side effects of new insulin sensitizers].
    Ludvik B
    MMW Fortschr Med; 2000 Jul; 142(28-29):27-8. PubMed ID: 10959156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.